期刊文献+

壮肾灵外敷治疗慢性心力衰竭30例

The Prostecdtive efficacy about the external effect of Zhuangshenling powder in patients with chronic Heart Failure for 30 cases
下载PDF
导出
摘要 目的的探讨壮肾灵外敷治心肾阳衰型慢性心力衰竭患者的远期疗效。方法 90例心肾阳衰型慢性心力衰竭患者中,中药组加用壮肾灵颗粒剂口服;外治组30例加用壮肾灵外敷心俞、肾俞穴;西药组仅口服西药。三组疗程均为24周。结果治疗24周后,中药组、外治组复发率均低于西药组;外治组BNP水平改善明显优于其余两组(P<0.05),外治组6分钟步行距离均优于其余两组。结论壮肾灵外敷能促进心肾阳衰型慢性心力衰竭患者心功能的恢复。 Objective To investigate external effect of Zhuang shen ling in Heart-kidney Yang deficiency syndrome of chronic heart failure patients, Methods According to the inclusion criteria, 90 cases of chronic heart failure patients were randomly divided into 3 groups, the traditional Chinese medicine group (30 cases) with Zhuangshenling granule, the group (30 cases) of external application of Xinshu (BL15) , Shenshu (BL23) with Zhuangshenling, and the conventional western medicine group (30 cases) . The course of treatment was 24 weeks. Results After 24 weeks of treatment, the recurrence rates in he traditional Chinese medicine group and the external application group were lower than he conventional western medicine group. The improvement of the level of BNP (brain natriuretic pepfide) in the external application group was significandy better than the other two groups (P〈0.05) , the external application group was also better than the other two groups in 6 minutes' walk test. Conclusion The external application with Zhuangshen ling can promote the recovery of Heart-kidney Yang deficiency syndrome of chronic heart failure patients.
出处 《中国中医药现代远程教育》 2014年第14期38-39,共2页 Chinese Medicine Modern Distance Education of China
关键词 壮肾灵 慢性心力衰竭 中药外治法 心悸 喘证 Zhuang shen ling chronic heart failure external treatment
  • 相关文献

参考文献2

二级参考文献3

  • 1Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B- type natriuretic peptide assay accurately diagnoses left ven- tricuiar dysfunction and evaluation [ J ]. Am Heart J, 2002, 144(5) : 834 -839.
  • 2Zaphiriou A, Robb S, Murray-Thomas T, et al. The diag- nostic accuracy of plasma BNP and NT-proBNP in patients referred from primary care with suspected heart failure: re- suits of the UK natriuretic peptide study [ J]. Eur J Heart Failure, 2005, 7(4) : 537 -541.
  • 3Koglin J, Pehlivanli S, Sohwaiblmair M, et al. Role of brain natriuretic peptide in risk stratification of patients with con- gestive heart failure[J]. J Am Coll Cardiol, 2001, 38(7) : 1934 - 1941.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部